• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种市售辅酶Q10制剂在比格犬体内的稳定性和生物等效性研究。

Stability and bioequivalence studies of two marketed formulations of coenzyme Q10 in beagle dogs.

作者信息

Kommuru T R, Ashraf M, Khan M A, Reddy I K

机构信息

Division of Basic Pharmaceutical Sciences, School of Pharmacy, College of Pharmacy and Health Sciences, Northeast Louisiana University, Monroe, LA-71209, USA.

出版信息

Chem Pharm Bull (Tokyo). 1999 Jul;47(7):1024-8. doi: 10.1248/cpb.47.1024.

DOI:10.1248/cpb.47.1024
PMID:10434405
Abstract

Coenzyme Q10 (CoQ10), a highly lipophilic compound present in the inner mitochondrial membrane, is essential for production of cellular energy in the form of ATP. CoQ10 is used as an antioxidant and also in the treatment of various cardiovascular disorders. The relative bioavailabilities of powder filled capsule (I) and oil-based formulation (II) of CoQ10 were compared in beagle dogs in an open, randomized, multiple dose, cross-over design. Poor and slow absorption characteristics were observed for both the formulations. The AUC, Cmax, and Tmax for formulation I and II are comparable (p < 0.05) where the values for formulation I are 22.84 +/- 6.3 micrograms ml-1 h, 0.51 +/- 0.11 microgram/ml, and 6.1 +/- 2.0 h whereas the values for formulation II are 24.32 +/- 5.6 micrograms ml-1 h, 0.55 +/- 0.16 microgram/ml, and 6.6 +/- 2.3 h, respectively. Stability of CoQ10 at various temperature and humidity conditions and its photostability were studied. Various antioxidants were evaluated to determine the type and amount of antioxidant(s) required to improve the stability of CoQ10. Large extent of degradation was observed at 45 degrees C and 55 degrees C. The effect of humidity conditions on degradation was insignificant. Among the various antioxidants studied, mixture of ascorbic acid (5%) and EDTA (0.1%) offered better protection than phenolic antioxidants such as butylated hydroxy anisole (BHA), butylated hydroxy toluene (BHT), or propyl gallate (PG). Further, increasing concentrations of phenolic antioxidants (from 0.1 to 0.3%) accelerated the degradation.

摘要

辅酶Q10(CoQ10)是一种存在于线粒体内膜的高度亲脂性化合物,对于以三磷酸腺苷(ATP)形式产生细胞能量至关重要。CoQ10用作抗氧化剂,也用于治疗各种心血管疾病。在比格犬中采用开放、随机、多剂量、交叉设计对比了CoQ10的粉末填充胶囊(I)和油基制剂(II)的相对生物利用度。两种制剂均观察到吸收不良和吸收缓慢的特性。制剂I和II的AUC、Cmax和Tmax具有可比性(p<0.05),其中制剂I的值分别为22.84±6.3微克·毫升⁻¹·小时、0.51±0.11微克/毫升和6.1±2.0小时,而制剂II的值分别为24.32±5.6微克·毫升⁻¹·小时、0.55±0.16微克/毫升和6.6±2.3小时。研究了CoQ10在不同温度和湿度条件下的稳定性及其光稳定性。评估了各种抗氧化剂,以确定提高CoQ10稳定性所需的抗氧化剂类型和用量。在45℃和55℃观察到大量降解。湿度条件对降解的影响不显著。在所研究的各种抗氧化剂中,抗坏血酸(5%)和乙二胺四乙酸(EDTA,0.1%)的混合物提供的保护优于酚类抗氧化剂,如丁基羟基茴香醚(BHA)、丁基羟基甲苯(BHT)或没食子酸丙酯(PG)。此外,酚类抗氧化剂浓度的增加(从0.1%至0.3%)加速了降解。

相似文献

1
Stability and bioequivalence studies of two marketed formulations of coenzyme Q10 in beagle dogs.两种市售辅酶Q10制剂在比格犬体内的稳定性和生物等效性研究。
Chem Pharm Bull (Tokyo). 1999 Jul;47(7):1024-8. doi: 10.1248/cpb.47.1024.
2
Bioavailability assessment of oral coenzyme Q10 formulations in dogs.犬口服辅酶Q10制剂的生物利用度评估
Drug Dev Ind Pharm. 2002 Nov;28(10):1195-200. doi: 10.1081/ddc-120015352.
3
Comparative bioavailability of two novel coenzyme Q10 preparations in humans.两种新型辅酶Q10制剂在人体中的比较生物利用度。
Int J Clin Pharmacol Ther. 2003 Jan;41(1):42-8. doi: 10.5414/cpp41042.
4
A new Coenzyme Q10 tablet-grade formulation (all-Q) is bioequivalent to Q-Gel and both have better bioavailability properties than Q-SorB.一种新的辅酶Q10片剂级配方(全Q)与Q-Gel具有生物等效性,且两者的生物利用度特性均优于Q-SorB。
J Med Food. 2005 Fall;8(3):397-9. doi: 10.1089/jmf.2005.8.397.
5
Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.不同辅酶Q10制剂与新型递送系统的相对生物利用度比较
Altern Ther Health Med. 2009 Mar-Apr;15(2):42-6.
6
Relative bioavailability and antioxidant potential of two coenzyme q10 preparations.两种辅酶Q10制剂的相对生物利用度和抗氧化潜力
Ann Nutr Metab. 2003;47(1):16-21. doi: 10.1159/000068910.
7
Relative bioavailability of two forms of a novel water-soluble coenzyme Q10.新型水溶性辅酶Q10两种形式的相对生物利用度
Ann Nutr Metab. 2008;52(4):281-7. doi: 10.1159/000129661. Epub 2008 Jul 22.
8
Bioavailability of coenzyme Q loaded in an oleogel formulation for oral therapy: Comparison with a commercial-grade solid formulation.辅酶 Q 负载于油凝胶制剂中的口服治疗的生物利用度:与商业级固体制剂的比较。
Int J Pharm. 2020 May 30;582:119315. doi: 10.1016/j.ijpharm.2020.119315. Epub 2020 Apr 10.
9
Comparison of bioavailability of two ubidecarenone products in healthy Korean volunteers.两种泛癸利酮产品在健康韩国志愿者体内的生物利用度比较。
Int J Clin Pharmacol Ther. 2009 Mar;47(3):207-14. doi: 10.5414/cpp47207.
10
Comparison of uptake between PureSorb-Q40 and regular hydrophobic coenzyme Q10 in rats and humans after single oral intake.单次口服后大鼠和人体中PureSorb-Q40与常规疏水辅酶Q10吸收情况的比较。
J Nutr Sci Vitaminol (Tokyo). 2007 Apr;53(2):187-90. doi: 10.3177/jnsv.53.187.

引用本文的文献

1
Synergistic effects of ginsenoside Rb1 and peroxiredoxin 6 in enhancing myocardial injury treatment through anti-inflammatory, anti-oxidative, and anti-apoptotic mechanisms.人参皂苷Rb1与过氧化物还原酶6通过抗炎、抗氧化和抗凋亡机制增强心肌损伤治疗的协同作用。
J Ginseng Res. 2025 Mar;49(2):145-155. doi: 10.1016/j.jgr.2024.11.003. Epub 2024 Nov 16.
2
Coenzyme Q Reduces Infarct Size in Animal Models of Myocardial Ischemia-Reperfusion Injury: A Meta-Analysis and Summary of Underlying Mechanisms.辅酶Q减少心肌缺血-再灌注损伤动物模型中的梗死面积:一项荟萃分析及潜在机制总结
Front Cardiovasc Med. 2022 Apr 15;9:857364. doi: 10.3389/fcvm.2022.857364. eCollection 2022.
3
Stability of Reduced and Oxidized Coenzyme Q10 in Finished Products.
成品中还原型和氧化型辅酶Q10的稳定性
Antioxidants (Basel). 2021 Feb 27;10(3):360. doi: 10.3390/antiox10030360.
4
Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction.载辅酶Q10脂质体对急性实验性心肌梗死家兔心肌的保护作用。
Pharm Res. 2007 Nov;24(11):2131-7. doi: 10.1007/s11095-007-9334-0. Epub 2007 Jul 27.
5
Solid-state nuclear magnetic resonance determination of the physical form of BHA on common pharmaceutical excipients.固态核磁共振法测定丁基羟基茴香醚在常见药用辅料上的物理形态
Pharm Res. 2004 Jan;21(1):185-8. doi: 10.1023/b:pham.0000012168.44628.ed.